• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Acton

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Eolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledgeEolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledge
    Eolas Medical
    21 Jan 2026

    Eolas Medical raises £9m Series A led by Acton Capital to give healthcare professionals access to on-demand medical knowledge

    Eolas Medical provides a clinical knowledge platform that gives healthcare professionals instant access to local guidelines, protocols and pathways at the point of care.

    Stotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contractsStotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contracts
    Stotles
    29 May 2025

    Stotles lands £10m Series A led by Headline and Acton to transform how companies win public sector contracts

    Stotles builds a platform that helps private companies identify, qualify and bid for public sector contracts, using data and AI to focus teams on realistic revenue opportunities.

Acton
    • Health
    • Sales
  • 2(12 months)
  • actoncapital.com
  • Update Information

More venture news

  • Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
    Shellworks
    4 Mar 2026

    Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation

    Series ASupply Chain
  • Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries
    Isembard
    9 Mar 2026

    Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries

    Series AIndustrial
  • Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
    Antiverse
    3 Mar 2026

    Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn